Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Agios Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 229 institutions reported holding Agios Pharmaceuticals, Inc. Largest: BlackRock, Vanguard and Farallon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Agios Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 6.46M | +701K | Aug 7, 2026 | |
| Vanguard | 6.07M | +350K | Aug 13, 2026 | |
| Farallon Capital Management, L.L.C. | 5.92M | +233K | Aug 14, 2026 | |
| State Street | 3.53M | +169K | Aug 7, 2026 | |
| Lynx1 Capital Management LP | 3.41M | +797K | Aug 13, 2026 | |
| D. E. Shaw & Co., Inc. | 3.11M | +426K | Aug 14, 2026 | |
| Armistice Capital, LLC | 2.4M | −316K | Aug 14, 2026 | |
| Erste Asset Management GmbH | 2.15M | −550K | Jul 28, 2026 | |
| Nomura | 2.11M | +616K | Aug 14, 2026 | |
| Geode Capital | 1.57M | +106K | Aug 12, 2026 |